Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.
Apply
Bimatoprost & LUMIGAN
Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step